Table 1.
X–ray crystal structures of AR LBD from Protein Data Bank and their 3D structural alignment complexed with various ligands.
PDB ID | AR type | Ligand | |
---|---|---|---|
1XQ3 | Wild type | AR agonist (R1881)14 |
![]() |
1T63 | Wild type | AR agonist (dihydrotestosterone; DHT)15 | |
2AX6 | T877A mutant | AR antagonist (hydroxyflutamide)16 | |
2AXA | Wild type | AR agonist (S1)16 | |
1Z95 | W741L mutant | AR antagonist (R-bicalutamide)17 | |
2OZ7 | T877A mutant | AR antagonist (cyproterone acetate)18 | |
2PIP | Wild type | AR agonist (DTH)/BF3 inhibitor (K10)19 | |
3V49 | Wild type | SARM (diarylhydantoins)20 | |
5JJM | Wild type | AR agonist (DHT)21 | |
5VO4 | Wild type | SARM (pyrrole-2-carbonitrile derivatives)22 |
The key mutant residues (W741, T877 and F876) near the binding site for the ligands are represented as colored in blue. Image was created by using Visual Molecular Dynamics (VMD) v1.9.352.